Temperature Effect on the Functional Expression of Human Cytochromes P450 2A6 and 2E1 in Escherichia coli |
Yim Sung-Kun
(School of Biological Sciences and Technology, Chonnam National University)
Ahn Taeho (Department of Biochemistry, College of Veterinary Medicine, Chonnam National University) Jung Heung-Chae (The National Research Laboratory of Microbial Display, GenoFocus, Inc., and Laboratory of Microbial Function, Korea Research Institute of Bioscience and Biotechnology) Pan Jae-Gu (The National Research Laboratory of Microbial Display, GenoFocus, Inc., and Laboratory of Microbial Function, Korea Research Institute of Bioscience and Biotechnology) Yun Chul-Ho (School of Biological Sciences and Technology, Chonnam National University, Hormone Research Institute, Chonnam National University) |
1 | Ahn, T., Yang, S., and Yun, C. H., High-level expression of human cytochrome P450 1A2 by co-expression with human molecular chaperone HDJ-1(Hsp40). Protein Expr. Purif., 36, 48-52 (2004b) DOI ScienceOn |
2 | Lieber, C. S., Cytochrome P-4502E1: its physiological and pathological role. Physiol. Rev., 77, 517-544 (1997) DOI |
3 | Oscarson, M., Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism. Drug Metab. Dispos., 29, 91-95 (2001) |
4 | Soucek, P., Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization, and preparation of polyclonal antibodies. Arch. Biochem. Biophys., 370, 190-200 (1999) DOI PUBMED ScienceOn |
5 | Guengerich, F. P., Kim, D. H., and Iwasaki, M., Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol., 4, 168-179 (1991) DOI ScienceOn |
6 | Iwata, H., Fujita, K., Kushida, H., Suzuki, A., Konno, Y., Nakamura, K., Fujino, A., and Kamataki, T., High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli. Biochem. Pharmacol., 55, 1315-1325 (1998) DOI PUBMED ScienceOn |
7 | Hanna, I. H., Teiber, J. F., Kokones, K. L., and Hollenberg, P. F., Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities. Arch. Biochem. Biophys., 350, 324-332 (1998) DOI ScienceOn |
8 | Inoue, E., Takahashi, Y., Imai, Y., and Kamataki, T., Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of cytochrome P450. Biochem. Biophys. Res. Commun., 269, 623-627 (2000) DOI ScienceOn |
9 | Pritchard, M. P., Ossetian, R., Li, D. N., Henderson, C. J., Burchell, B., Wolf, C. R., and Friedberg, T., A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1. Arch. Biochem. Biophys., 345, 342-354 (1997) DOI ScienceOn |
10 | Oyama, T., Kawamoto, T., Mizoue, T., Sugio, K., Kodama, Y., Mitsudomi, T., and Yasumoto, K., Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res., 17, 583-587 (1997) |
11 | Yamazaki, H., Inoue, K., Mimura, M., Oda, Y., Guengerich, F. P., and Shimada, T., 7-Ethoxycoumarin O-deethylation catalyzed by cytochromes P450 1A2 and 2E1 in human liver microsomes. Biochem. Pharmacol., 51, 313-319 (1996) DOI ScienceOn |
12 | Guengerich, F. P. and Parikh, A., Expression of drug-metabolizing enzymes. Curr. Opin. Biotechnol., 8, 623-628 (1997) DOI ScienceOn |
13 | Yun, C. H., Shimada, T., and Guengerich, F. P., Purification and characterization of human liver microsomal cytochrome P- 450 2A6. Mol. Pharmacol., 40, 679-685 (1991) |
14 | Fujieda, M., Yamazaki, H., Saito, T., Kiyotani, K., Gyamfi, M. A., Sakurai, M., Dosaka-Akita, H., Sawamura, Y., Yokota, J., Kunitoh, H., and Kamataki, T., Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis, (2004) (Aug. 12, web edition) DOI ScienceOn |
15 | Omura, T. and Sato, R., The Carbon Monoxide-Binding Pigment of Liver Microsomes. I. Evidence for Its Hemoprotein Nature. J. Biol. Chem., 239, 2370-2378 (1964) |
16 | Sandhu, P., Baba, T., and Guengerich, F. P., Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch. Biochem. Biophys., 306, 443-450 (1993) DOI ScienceOn |
17 | Ahn, T., Yang, S., and Yun, C. H., Enhanced expression of human cytochrome P450 1A2 by co-expression with human molecular chaperone Hsp70. Toxicol. Lett., 153, 267-272 (2004a) DOI ScienceOn |
18 | Wrighton, S. A. and Stevens, J. C., The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol., 22, 1-21 (1992) DOI ScienceOn |
19 | Dong, M. S., Yamazaki, H., Guo, Z., and Guengerich, F. P., Recombinant human cytochrome P450 1A2 and an Nterminal- truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Arch. Biochem. Biophys., 327, 11-19 (1996) DOI ScienceOn |
20 | Peter, R., Bocker, R., Beaune, P. H., Iwasaki, M., Guengerich, F. P., and Yang, C. S., Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem. Res. Toxicol., 3, 566-573 (1990) DOI ScienceOn |
21 | Gillam, E. M., Guo, Z., and Guengerich, F. P., Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch. Biochem. Biophys., 312, 59-66 (1994) DOI ScienceOn |
22 | Tricker, A. R., Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology, 183, 151-173 (2003) DOI PUBMED ScienceOn |
23 | Raucy, J. L., Schultz, E. D., Wester, M. R., Arora, S., Johnston, D. E., Omdahl, J. L., and Carpenter, S. P., Human lymphocyte cytochrome P450 2E1, a putative marker for alcoholmediated changes in hepatic chlorzoxazone activity. Drug Metab. Dispos., 25, 1429-1435 (1997) |
24 | Barnes, H. J., Arlotto, M. P., and Waterman, M. R., Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A., 88, 5597-5601 (1991) DOI ScienceOn |
25 | Parikh, A. and Guengerich, F. P., Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein. Protein Expr. Purif., 9, 346-354 (1997) DOI ScienceOn |
26 | Yamazaki, H., Inui, Y., Yun, C. H., Guengerich, F. P., and Shimada, T., Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis, 13, 1789-1794 (1992) DOI ScienceOn |
27 | Guengerich, F. P., Human cytochrome P450 enzymes. In Cytochrome P450, 2nd ed., P. R. Ortiz de Montelano, ed (New York: Plenum), pp. 473-535 (1995) |
28 | Tsukino, H., Kuroda, Y., Qiu, D., Nakao, H., Imai, H., and Katoh, T., Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma. Int. J. Cancer, 100, 425-428 (2002) DOI ScienceOn |
29 | Ahn, T. and Yun, C. H., High-level expression of human cytochrome P450 3A4 by co-expression with human molecular chaperone HDJ-1 (Hsp40). Arch. Pharm. Res., 27, 319-323 (2004) DOI ScienceOn |
30 | Roberts, B. J., Shoaf, S. E., Jeong, K. S., and Song, B. J., Induction of CYP2E1 in liver, kidney, brain and intestine during chronic ethanol administration and withdrawal: evidence that CYP2E1 possesses a rapid phase half-life of 6 hours or less. Biochem. Biophys. Res. Commun., 205, 1064-1071 (1994) DOI ScienceOn |